Major Bipartisan Bill to Combat Opioid Crisis Passes Senate, Includes Key Measures Authored by Senator Hassan

Statement

Date: Sept. 17, 2018
Location: Washington, DC

Senator Maggie Hassan, a member of the Senate Health, Education, Labor, and Pensions (HELP) Committee voted to approve a major bipartisan bill to combat the deadly opioid epidemic that is ravaging communities in New Hampshire and across the country. The bipartisan legislation includes the Opioid Crisis Response Act, which Senator Hassan helped develop as a member of the HELP Committee, as well as other key measures that the Senator either authored or cosponsored to strengthen prevention, treatment, recovery, and law enforcement efforts.

"This bipartisan bill will help those on the front lines of the opioid crisis save lives," Senator Hassan said. "From expanding access to medication-assisted treatment, to helping ensure that the states hardest hit by this crisis like the Granite State receive their fair share of federal resources, to expanding comprehensive recovery centers, and supporting brave law enforcement officers and first responders, this legislation includes many critical priorities I have long fought for. As the Senate moves this legislation into negotiations with the U.S. House of Representatives, I will work with members of both parties to continue to improve this legislation so that we can get it passed without delay."

The bipartisan legislation includes a number of measures that Senator Hassan either authored or cosponsored to advance to help turn the tide of this epidemic and save lives, including ensuring that states hardest-hit by the epidemic like New Hampshire receive their fair share of resources; establishing comprehensive recovery centers for those struggling with addiction; expanding access to medication-assisted treatment; improving recovery housing opportunities; supporting law enforcement in their efforts to curb the shipment of deadly fentanyl into the United States from other countries, crack down on bad actors in the pharmaceutical industry, and more.


Source
arrow_upward